Dalphene Labs · The business of medical aestheticsFor owners, injectors & clinic teamsJoin the brief
Daily edition

Dalphene Labs

Medical aesthetics
Industry

Deals, market moves, supply, and new products and approvals.

50 briefs · page 5 of 5

Industry, page 5

12345Back to page 1 →
FDA approves Obagi saypha ChIQ, its second US filler

Industry

FDA approves Obagi saypha ChIQ, its second US filler

A cheek and midface HA gel builds out Obagi's injectable line, with the ALOHA data hinting at the real play.

Read the brief →
Foreign patients spent $8.3 billion on Korean medical services in 2025

Industry

Foreign patients spent $8.3 billion on Korean medical services in 2025

Dermatology, not surgery, drives a record 2.01 million foreign patients.

Read the brief →